LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,577,814 | -12.6% | 797,645 | -10.2% | 0.01% | -16.7% |
| Q2 2023 | $61,323,630 | +196.6% | 888,362 | +107.2% | 0.01% | +200.0% |
| Q1 2023 | $20,674,422 | +56.1% | 428,752 | +61.6% | 0.00% | 0.0% |
| Q4 2022 | $13,244,575 | +35.3% | 265,316 | +10.6% | 0.00% | +100.0% |
| Q3 2022 | $9,791,000 | +16.4% | 239,978 | +56.9% | 0.00% | 0.0% |
| Q2 2022 | $8,413,000 | +70.8% | 152,965 | +12.9% | 0.00% | 0.0% |
| Q1 2022 | $4,926,000 | -32.7% | 135,538 | -13.7% | 0.00% | 0.0% |
| Q4 2021 | $7,319,000 | -23.5% | 157,023 | -17.0% | 0.00% | 0.0% |
| Q3 2021 | $9,571,000 | +304.0% | 189,291 | +228.0% | 0.00% | – |
| Q2 2021 | $2,369,000 | +71.7% | 57,707 | +21.4% | 0.00% | – |
| Q1 2021 | $1,380,000 | -56.8% | 47,546 | -58.1% | 0.00% | – |
| Q4 2020 | $3,195,000 | +337.1% | 113,465 | +379.1% | 0.00% | – |
| Q3 2020 | $731,000 | -42.1% | 23,681 | -20.2% | 0.00% | – |
| Q2 2020 | $1,262,000 | – | 29,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |